InvestorsHub Logo
Followers 12
Posts 511
Boards Moderated 0
Alias Born 03/14/2017

Re: iwasadiver post# 127424

Tuesday, 07/25/2017 10:42:21 PM

Tuesday, July 25, 2017 10:42:21 PM

Post# of 682066
That makes too much sense.

Initially, I was as disappointed as many others that did not mention DCVAX-L or NWBO. Then I re-read the article now with the discussion that's been going on here and I think she did the right thing by not bringing too much attention to NWBO or DCVAX-L directly.

1. The author of the article was very careful not to mention any of the unapproved companies / drugs / 100s of clinical trials.

2. The article is derivative and we don't know exactly what Dr. Liau said verbatim and in what context.

3. What concerns me is the following: Again, probably out of context, but nonetheless: 'Liau, like other scientists I spoke to, doesn’t see a future one-size-fits-all drug, especially with a disease that is so internally diverse, but she does see hope.

“I think everyone anecdotally are seeing some patients respond really well and do really well, but we don’t know how to identify those people prospectively for treatment and trials,” she said. “I do think we’re making progress in small pockets.”'
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News